High Serum Cartilage Oligomeric Matrix Protein Determines the Subset of Patients with Early-Stage Rheumatoid Arthritis with High Serum C-Reactive Protein, Matrix Metalloproteinase-3, and MRI-Proven Bone Erosion

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Rheumatology

• Publication date

  2009-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3899/jrheum.080926PMID 19447929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis.

  2007cited by this paper
• Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheumatoid arthritis.

  2007cited by this paper
• Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values

  2006cited by this paper
• Association of higher levels of serum cartilage oligomeric matrix protein and N-telopeptide crosslinks with the development of radiographic hip osteoarthritis in elderly women.

  2006cited by this paper
• Severe relapse of Wegener’s granulomatosis during the early postpartum period

  2005cited by this paper
• Prognostic laboratory markers of joint damage in rheumatoid arthritis

  2004cited by this paper
• Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.

  2004cited by this paper
• Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.

  2004cited by this paper
• Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis.

  2003cited by this paper
• Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis.

  2003cited by this paper
• Long term anti-tumour necrosis factor α monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation

  2002cited by this paper
• Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.

  1999cited by this paper
• The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip.

  1991cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

  1986cited by this paper

• Joint Tissues: Convergence and Divergence of the Pathogenetic Mechanisms of Rheumatoid Arthritis and Osteoarthritis

  2025cites this paper
• Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity

  2023cites this paper
• The role of monitoring the level of matrix metalloproteinase 3 in patients with rheumatoid arthritis on anti-B-cell therapy

  2022cites this paper
• Objective and noninvasive biochemical markers in rheumatoid arthritis: where are we and where are we going?

  2021influential citation
• Predictors of radiographic erosion and joint space narrowing progression in patients with early rheumatoid arthritis: a cohort study

  2020cites this paper
• MMP3 is a reliable marker for disease activity, radiological monitoring, disease outcome predictability, and therapeutic response in rheumatoid arthritis.

  2018cites this paper
• Role of cartilage oligomeric matrix protein (COMP) as a prognostic biomarker in follow-up of early rheumatoid arthritis patients: Correlation to musculoskeletal ultrasonographic findings

  2018cites this paper
• 3 Tesla magnetic resonance imaging and computerised image analysis in the evaluation of rheumatoid hand joints

  2018cites this paper
• The degree of cartilage degradation assessed by serum biomarker levels changes after arthroscopic knee synovectomy in rheumatoid arthritis patients

  2017cites this paper
• Rheumatoid Arthritis: Hyaluronic Acid and Cartilage Oligomeric Matrix Protein as Predictors of the Disease Progression

  2016cites this paper
• Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis

  2016cites this paper
• [Relationship between matrix metalloproteinase-3 levels and articular destructive changes in early and extended rheumatoid arthritis].

  2016cites this paper
• An Exploratory Study of the Diurnal Variation and Reliability of Biomarkers Related to Physiological Damage Experienced in Work-Related Musculoskeletal Disorders

  2015cites this paper
• Clinical and laboratory markers of disease activity and response to therapy in South Africans with rheumatoid arthritis with disease duration less than two years

  2015cites this paper
• The Effects of Aerobic and Resistance Exercise on Markers of Large Joint Health in Stable Rheumatoid Arthritis Patients: A Pilot Study.

  2015cites this paper
• The Relationship of Antibodies to Modified Citrullinated Vimentin and Markers of Bone and Cartilage Destruction in Rheumatoid Arthritis

  2014cites this paper
• Клиническое значение матриксных металлопротеиназ при ревматоидном артрите (обзор литературы и собственные данные)

  2014cites this paper
• Biomarkers of cartilage and surrounding joint tissue.

  2014cites this paper
• Biomarkers of Physiological Damage and their Potential for Work-Related Musculoskeletal Disorder Risk Assessment

  2014cites this paper
• Clinical Study Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis

  2014cites this paper
• Matrix-assisted laser desorption ionization-imaging mass spectrometry: a new methodology to study human osteoarthritic cartilage.

  2013cites this paper
• Anti-granulocyte scintigraphy in early rheumatoid arthritis — does it work?

  2013cites this paper
• 34 – Biologic Markers

  2013cites this paper
• Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis

  2013cites this paper
• Exercise and joint health in rheumatoid arthritis

  2012cites this paper
• Relations of Serum COMP to Cardiovascular Risk Factors and Endothelial Function in Patients with Rheumatoid Arthritis Treated with Methotrexate and TNF-α Inhibitors

  2012cites this paper
• Les marqueurs biochimiques utiles à l’exploration des atteintes ostéo-articulaires de la polyarthrite rhumatoïde

  2012cites this paper
• Magnetic resonance imaging (MRI) detection of synovitis and bone lesions of the wrists and finger joints in early-stage rheumatoid arthritis: comparison of the accuracy of plain MRI-based findings and gadolinium-diethylenetriamine pentaacetic acid-enhanced MRI-based findings

  2012cites this paper
• Downregulation of the Inflammatory Response by CORM-3 Results in Protective Effects in a Model of Postmenopausal Arthritis

  2012cites this paper
• Molecular serum and urine marker repertoire supporting clinical research on joint diseases.

  2011cites this paper
• Biochemical markers of ongoing joint damage in rheumatoid arthritis - current and future applications, limitations and opportunities

  2011cites this paper
• Value of Entheseal Ultrasonography and Serum Cartilage Oligomeric Matrix Protein in the Preclinical Diagnosis of Psoriatic Arthritis

  2010cites this paper
• Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis

  2010cites this paper
• Serum Levels of Hyaluronic Acid (HA) and Cartilage Oligomeric Matrix Protein (COMP). Predictors of Disease Progression in Rheumatoid Arthritis

  2009cites this paper